Education
About Us
Working with TipRanks
Follow Us
Beta Drugs Ltd. (IN:BETA)
:BETA
BETA Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹1,047.62 - ₹2,215.24
Previous CloseN/A
Volume3.10K
Average Volume (3M)3.21K
Market Cap
₹19.30B
Enterprise Value₹15.33B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)47.1
Beta0.91
Next Earnings
Apr 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)40.62
Shares Outstanding10,094,553
10 Day Avg. Volume2,824
30 Day Avg. Volume3,205
Financial Highlights & Ratios
PEG Ratio2.62
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BETA FAQ
What was Beta Drugs Ltd.’s price range in the past 12 months?
Beta Drugs Ltd. lowest stock price was ₹1047.62 and its highest was ₹2215.24 in the past 12 months.
What is Beta Drugs Ltd.’s market cap?
Beta Drugs Ltd.’s market cap is ₹19.30B.
When is Beta Drugs Ltd.’s upcoming earnings report date?
Beta Drugs Ltd.’s upcoming earnings report date is Apr 23, 2025 which is today.
How were Beta Drugs Ltd.’s earnings last quarter?
Beta Drugs Ltd. released its earnings results on Nov 06, 2024. The company reported ₹23.81 earnings per share for the quarter, beating the consensus estimate of N/A by ₹23.81.
Is Beta Drugs Ltd. overvalued?
According to Wall Street analysts Beta Drugs Ltd.’s price is currently Overvalued.
Does Beta Drugs Ltd. pay dividends?
Beta Drugs Ltd. does not currently pay dividends.
What is Beta Drugs Ltd.’s EPS estimate?
Beta Drugs Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beta Drugs Ltd. have?
Beta Drugs Ltd. has 10,094,553 shares outstanding.
What happened to Beta Drugs Ltd.’s price movement after its last earnings report?
Beta Drugs Ltd. reported an EPS of ₹23.81 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.076%.
Which hedge fund is a major shareholder of Beta Drugs Ltd.?
Currently, no hedge funds are holding shares in IN:BETA
---
Technical Analysis
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―
---